Cyclin dependent kinase inhibitors as a new potential therapeutic option in management of COVID-19

Med Hypotheses. 2021 Jan:146:110380. doi: 10.1016/j.mehy.2020.110380. Epub 2020 Nov 8.
No abstract available

Publication types

  • Letter

MeSH terms

  • COVID-19 / enzymology
  • COVID-19 Drug Treatment*
  • Cell Cycle / drug effects
  • Cell Division / drug effects
  • Cyclin-Dependent Kinases / antagonists & inhibitors*
  • Humans
  • Protein Kinase Inhibitors / pharmacology
  • Protein Kinase Inhibitors / therapeutic use*
  • SARS-CoV-2 / drug effects*
  • SARS-CoV-2 / physiology
  • Virus Replication / drug effects

Substances

  • Protein Kinase Inhibitors
  • Cyclin-Dependent Kinases